ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 736163 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 736163; 2) Community: the network communities that were significantly associated with the response to NSC 736163; 3) Molecule: the relationships between components within communities and NSC 736163; 4) MDR: the compounds that were significantly associated with the NSC 736163.

NSC Compound Enrichment Correlation
NSC 717468 Null 0.022188614181866 0.29400582
NSC 718781 Erlotinib hydrochloride 0.022188614181866 -0.21612811
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.022188614181866 0.29746608
NSC 725098 Null 0.022188614181866 0.28191672
NSC 726217 Combretastatin A4-analogue 0.022188614181866 0.31644053
NSC 731704 1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. 0.022188614181866 0.33382929
NSC 732936 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.022188614181866 0.4096879
NSC 733149 Null 0.022188614181866 0.34703993
NSC 743532 Null 0.022188614181866 0.2598898
NSC 752278 2,7-Bis-[2-(2,3,4-trimethoxy-benzylamino)-ethyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone di-p-toluensulfonate salt 0.022188614181866 0.24424991
Total:141  Current:84    [First] [Prev] [Next] [Last]